EUCTR2006-005796-18-NL进行中（未招募）不适用
Does antenatal allopurinol during asphyxia reduce post-hypoxic-ischemic reperfusion damage in the newborn? - ALLO-trial
WKZ / UMC Utrecht0 个研究点开始时间: 2009年5月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Gestational age of 36 weeks or more, determined by maternal dates and/or Ballard score.
- •Objective fetal hypoxia registered by:
- •? Abnormalities on STAN S21 fetal electrocardiography monitor (Neoventa Medical, Gothenborg, Sweden). OR
- •? Two or more suboptimal CTG recordings (according to CTG-classification) OR
- •? An abnormal / preterminal CTG recording (according to CTG-classification, see page 10) OR
- •? Fetal blood sampling: pH<7.20
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Congenital, chromosomal or syndromal malformations.
研究者
相似试验
已完成
不适用
Perinatal allopurinol trial for reduction of birth asphyxia induced brain damage.perinatal asphyxia, neuroprotection, allopurinol, newborn, oxidative stressNL-OMON28692Prof dr. F. van Bel220
Unknown
3 期
Antenatal Allopurinol During Fetal HypoxiaFetal HypoxiaReperfusion InjuryNCT00189007UMC Utrecht222
已完成
3 期
Does antenatal allopurinol during perinatal asphyxia reduce post-hypoxic-ischemic reperfusion damage in the newborn? A double blind randomised placebo controlled multicenter trial.10028920brain damageEncephalopathy10010335NL-OMON36929niversitair Medisch Centrum Utrecht220
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
已完成
不适用
Allopurinol as a possible oxygen sparing agent during exercise in peripheral arterial diseaseCirculatory SystemOther peripheral vascular diseasesPeripheral arterial diseaseISRCTN01772998niversity of Dundee (UK)50